MedPath

Comparison of effect of pelvic floor exercise and sex education on sexual function in postmenopausal wome

Not Applicable
Conditions
Sexual dysfunction.
Sexual dysfunction, not caused by organic disorder or disease
Registration Number
IRCT2014120320201N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
150
Inclusion Criteria

Inclusion Criteria: Natural menopause (neither surgical nor premature menopause); age 40-60, not having been more than 3 years since the onset of menopause; lack of acute heart diseases; lack of any serious mental illness; absence of severe psychological stress such as an accident or loss of a family member in the past 3 months; having sexual intercourse with husband; the absence of sexual dysfunction in husband; not using herbal medicines containing phytoestrogens or supplements of sexual hormones in any form; not having a drug abuser spouse; having the willingness to participate in interventions to improve sexual function

Exclusion criteria: Being unwilling to cooperate in the ongoing investigation; having debilitating diseases (such as cancer) which prevent the person from participating in interventions; having a surgery during the intervention; having marital discord, divorce, death or illness of spouse during the intervention

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of sexual function. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Female Sexual Function Index (FSFI) questionnaire.;Life Quality. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: WHO Quality of Life-BREF (WHOQOL-BREF) questionnaire.;Severity of menopausal symptoms. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Menopause Rating Scale (MRS) questionnaire.;Total Testosterone. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzyme immunoasay (EIA).;Dehydroepiandrosterone Sulfate (DHEAS). Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzyme immunoasay (EIA).;SHBG. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzymo-immunometric assay (EIMA).;EStradiol. Timepoint: Before Intervention, 3 months after intervention. Method of measurement: Enzyme-Linked Fluorescent Immunoassay (FLFA).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath